Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

@article{Bavry2010OutcomesAH,
  title={Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.},
  author={Anthony A Bavry and Russell Anderson and Yan Gong and Scott J. Denardo and Rhonda M. Cooper-Dehoff and Eileen M Handberg and Carl J Pepine},
  journal={Hypertension},
  year={2010},
  volume={55 1},
  pages={48-53}
}
Hypertension is a common risk factor for peripheral arterial disease (PAD). Guidelines suggest treating PAD patients to a blood pressure <130/80 mm Hg; therefore, our objective was to explore whether attainment of this target blood pressure is associated with improved outcomes. We performed a post hoc analysis of the INternational VErapamil-SR/Trandolapril STudy, a randomized clinical trial, which included hypertensive patients with concomitant PAD and coronary artery disease. There were 2699… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health ( REACH ) Registry

  • SE Hoeks, WJ ScholteopReimer, +8 authors D Poldermans
  • Atherosclerosis
  • 2009

Similar Papers

Loading similar papers…